HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL Biotechnology is proud to announce its inclusion in the Choiseul Conquérants 2025 ranking, which highlights French mid-sized companies (ETIs) committed to innovation, job creation, and the expansion into new markets.
Being recognized by the Institut Choiseul for the second year in a row is a strong acknowledgment of our daily commitment and the collective momentum driven by our teams.
We thank the Institut Choiseul for this recognition and congratulate all the companies featured in the ranking.
Read the dedicated articles published:
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.